IP Library Granted Patent US 12,674,283
Granted Patent B2
US 12,674,283 · App. 18/013,735 · Granted Jul 7, 2026

Coreless rolls of a tissue paper product and methods of manufacturing coreless rolls

Inventors: Sébastien Jeannot (Kunheim, FR); Nicolas Weisang (Kunheim, FR)
Assignee: ESSITY HYGIENE AND HEALTH AKTIEBOLAG
D21H27/005A47K10/16B31F1/07B31F1/36B32B3/30B32B7/05B32B7/12B32B29/005B32B29/06B32B29/08B65H18/28D21H27/004D21H27/02D21H27/32D21H27/38D21H27/40B31F2201/0764B31F2201/0774B32B2250/26B32B2307/54B32B2307/718B32B2307/72B32B2307/732B32B2307/7376B65H2301/5126B65H2701/18422B65H2701/1924
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,674,283
App. No.
18/013,735
Filed
Dec 29, 2022
Granted
Jul 7, 2026
Kind
B2
Art Unit
1781
USPC
428/154
Abstract

Disclosed is a coreless roll of a tissue paper product made of a spirally wound continuous web having a first end and second end and an outer diameter in the range of 95 to 150 mm, the web of tissue paper product being wound to define an inner hole centrally positioned relative to the coreless roll such that the first end is located on the outer side of the coreless roll and the second end is located at the inner hole, a diameter of the inner hole being 20 to 50 mm, a density of the coreless roll being 80 to 150 kg/m 3 , and a caliper ratio of the roll being 10% to 80%, the tissue paper product including between two and four ply-bonded plies, at least one ply being Conventional Wet Press, and at least one ply being a structured ply.

Claims (92)

1 . A coreless roll of a tissue paper product, such as toilet paper, made of a spirally wound continuous web of tissue paper product having a first end and a second end, the web of tissue paper product being wound such as to define an axially extending inner hole centrally positioned relative to the coreless roll and such that the first end is located on the outer side of the coreless roll and the second end is located at the inner hole,

wherein the tissue paper product comprises two plies, being a first ply and a second ply, the first ply and the second ply being ply-bonded, optionally using an adhesive such as lamination glue and/or mechanical bonding, such as edge embossing, to form the tissue paper product, and

a grammage of the tissue paper product being in a range of 24 to 50 g/m 2 , and wherein

the first ply is made of Conventional Wet Press (CWP) paper,

the second ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT, and

the first ply has been embossed with a heated embossing roll, the coreless roll has an outer diameter in the range of 95 to 150 mm, a diameter of the inner hole is in the range of 20 to 50 mm, and a density of the coreless roll is in a range of 80 to 150 kg/m 3 , and

a caliper ratio of the roll is in a range of 30% to 80%,

the caliper ratio (c s −c t )/c t being obtained by dividing a difference between a standard caliper c s of the tissue paper product as defined by the standard ISO-12625-3:2014 and a theoretical caliper c t of the tissue paper product by the theoretical caliper c t , and

the theoretical caliper c t being defined as a ratio between a grammage of the tissue paper product and the density of the roll.

2 . The coreless roll of a tissue paper product of claim 1 , wherein the tissue paper product has a caliper of at least 0.35 mm, optionally at least 0.40 mm, or at least 0.45 mm.

3 . The coreless roll of a tissue paper product of claim 1 , the two plies being a first ply and a second ply,

wherein the first ply comprises first embossments with a first height (h1), the first height (h1) being in a range of 0.2 mm to 2.0 mm,

wherein the second ply comprises second embossments with a second height (h2), the second height (h2) being in a range of 0.2 mm to 2.0 mm,

wherein the adhesive, such as lamination glue, is optionally applied to tips of the first embossments of the first ply and/or to tips of the second embossments of the second ply, and

wherein the first ply optionally comprises third embossments with a third height (h3) smaller than the first height (h1) (h1>h3), the third height (h3) being in a range of 0.1 mm to 1.2 mm.

4 . The coreless roll of a tissue paper product of claim 3 ,

wherein the first embossments have been formed by the heated embossing roll and, optionally, the third embossments have been formed by the heated embossing roll,

and/or wherein the second embossments have been formed by a second heated embossing roll,

and/or wherein the third embossments have been formed by a third heated embossing roll,

and/or wherein, optionally, the first ply has been moistened, prior to having been embossed, with an amount of liquid, such as water, in the range of 2% to 12% of the basis weight of the first ply, or optionally 4% to 10% of the basis weight of the first ply, wherein the liquid optionally is provided with one or several additives, or wherein the first ply has not been moistened with a liquid prior to having been embossed.

5 . The coreless roll of a tissue paper product of claim 1 , wherein a geometrical mean tensile strength of tissue paper product of the coreless roll lies in a range of 70 N/m to 210 N/m, optionally 90 N/m to 210 N/m, or 110 N/m to 210 N/m.

6 . A coreless roll of a tissue paper product, such as toilet paper, made of a spirally wound continuous web of tissue paper product having a first end and a second end, the web of tissue paper product being wound such as to define an axially extending inner hole centrally positioned relative to the coreless roll and such that the first end is located on the outer side of the coreless roll and the second end is located at the inner hole,

wherein the tissue paper product comprises three plies, the three plies being a first ply, a second ply, and a third ply, wherein the first ply is one of the outermost plies of the tissue paper product, and the three plies are ply-bonded, optionally using an adhesive such as lamination glue and/or mechanical bonding, such as edge embossing, to form the tissue paper product, and

wherein the grammage of the tissue paper product is in a range of 34 g/m 2 to 65 g/m 2 , optionally 40 g/m 2 to 63 g/m 2 , or 45 g/m 2 to 60 g/m 2 , and wherein

the first ply is made of Conventional Wet Press (CWP) paper,

the second ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT, and

the first ply has been embossed with a heated embossing roll,

the coreless roll has an outer diameter in the range of 95 to 150 mm, a diameter of the inner hole is in the range of 20 to 50 mm, and a density of the coreless roll is in a range of 90 to 150 kg/m 3 , and

a caliper ratio of the roll is in a range of 20% to 60%,

the caliper ratio (c s −c t )/c t being obtained by dividing a difference between a standard caliper c s of the tissue paper product as defined by the standard ISO-12625-3:2014 and a theoretical caliper c t of the tissue paper product by the theoretical caliper c t , and

the theoretical caliper c t being defined as a ratio between a grammage of the tissue paper product and the density of the roll.

7 . The coreless roll of a tissue paper product of claim 6 , wherein the tissue paper product has a caliper of at least 0.40 mm, optionally at least 0.45 mm, or at least 0.50 mm.

8 . The coreless roll of a tissue paper product of claim 6 ,

wherein the first ply comprises first embossments with a first height (h1), the first height (h1) being in a range of 0.2 mm to 2.0 mm,

wherein the second ply comprises second embossments with a second height (h2), the second height (h2) being in a range of 0.2 mm to 2.0 mm,

wherein the adhesive, such as lamination glue, is optionally applied to tips of the first embossments of the first ply and/or tips of the second embossments of the second ply, and

wherein the first ply optionally comprises third embossments with a third height (h3) smaller than the first height (h1) (h1>h3), the third height (h3) being in a range of 0.1 mm to 1.2 mm.

9 . The coreless roll of a tissue paper product of claim 8 , wherein the third ply has not been embossed prior to ply-bonding, wherein the third ply is, optionally, only partially embossed at locations where it is ply-bonded with the first ply or the second ply, and/or the third ply is made of Conventional Wet Press (CWP) paper or the third ply is a structured paper ply, such as such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT.

10 . The coreless roll of a tissue paper product of claim 8 , wherein the first ply and the third ply have been embossed together to form the first embossments on the first ply and the third ply, and

wherein, optionally, the third embossments have been formed only on the first ply but not on the third ply, or, wherein, optionally, the first ply and the third ply have been embossed together to form the third embossments on the first ply and the third ply.

11 . The coreless roll of a tissue paper product of claim 8 , wherein the third ply comprises fourth embossments with a fourth height (h4), the fourth height (h4) being in a range of 0.2 mm to 2.0 mm, and wherein the third ply has been embossed separately from the first ply and the second ply,

wherein, optionally, the fourth embossments have been formed by a fourth heated embossing roll.

12 . The coreless roll of a tissue paper product of claim 8 ,

wherein the first embossments have been formed by the heated embossing roll, and/or,

wherein the second embossments have been formed by a second heated embossing roll, and/or,

wherein the third embossments have been formed by the heated embossing roll or a third heated embossing roll, and/or

wherein, optionally, the first ply has been moistened, prior to having been embossed, with an amount of liquid, such as water, in the range of 2% to 12% of the basis weight of the first ply, or optionally 4% to 10% of the basis weight of the first ply, wherein the liquid optionally is provided with one or several additives, or wherein the first ply has not been moistened with a liquid prior to having been embossed.

13 . The coreless roll of a tissue paper product of claim 6 , wherein a geometrical mean tensile strength of tissue paper product of the coreless roll lies in a range of 100 N/m to 280 N/m, optionally 120 N/m to 280 N/m, or 140 N/m to 280 N/m.

14 . A coreless roll of a tissue paper product, such as toilet paper, made of a spirally wound continuous web of tissue paper product having a first end and a second end, the web of tissue paper product being wound such as to define an axially extending inner hole centrally positioned relative to the coreless roll and such that the first end is located on the outer side of the coreless roll and the second end is located at the inner hole,

wherein the tissue paper product comprises four plies, the four plies being a first ply, a second ply, a third ply, and a fourth ply, wherein the first ply is one of the outermost plies of the tissue paper product, and the four plies are ply-bonded, optionally using an adhesive such as lamination glue and/or mechanical bonding, such as edge embossing, to form the tissue paper product, and

the grammage of the tissue paper product is in a range of 55 g/m 2 to 95 g/m 2 , or optionally 60 g/m 2 to 80 g/m 2 , and wherein

the first ply is made of Conventional Wet Press (CWP) paper,

the second ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT, and

the first ply has been embossed with a heated embossing roll,

the coreless roll has an outer diameter in the range of 95 to 150 mm, a diameter of the inner hole is in the range of 20 to 50 mm, and a density of the coreless roll is in a range of 110 to 150 kg/m 3 , and

a caliper ratio of the roll is in a range of 12% to 40%,

the caliper ratio (c s −c t )/c t being obtained by dividing a difference between a standard caliper c s of the tissue paper product as defined by the standard ISO-12625-3:2014 and a theoretical caliper c t of the tissue paper product by the theoretical caliper c t , and

the theoretical caliper c t being defined as a ratio between a grammage of the tissue paper product and the density of the roll.

15 . The coreless roll of a tissue paper product of claim 14 , wherein the tissue paper product has a caliper of at least 0.55 mm, optionally at least 0.60 mm, or at least 0.65 mm.

16 . The coreless roll of a tissue paper product of claim 14 ,

wherein the first ply comprises first embossments with a first height (h1), the first height (h1) being in a range of 0.2 mm to 2.0 mm,

wherein the second ply comprises second embossments with a second height (h2), the second height (h2) being in a range of 0.2 mm to 2.0 mm,

wherein the adhesive, such as lamination glue, is optionally applied to tips of the first embossments of the first ply and/or tips of the second embossments of the second ply, and

wherein the first ply optionally comprises third embossments with a third height (h3) smaller than the first height (h1) (h1>h3), the third height (h3) being in a range of 0.1 mm to 1.2 mm.

17 . The coreless roll of a tissue paper product of claim 16 , wherein the first ply and the third ply have been embossed together to form the first embossments on the first ply and the third ply,

wherein the fourth ply is unembossed or has been embossed separately from the first ply, the second ply, and the third ply to form fourth embossments, the fourth embossments optionally having been embossed by a fourth heated embossing roll, and

wherein the third embossments have optionally been formed only on the first ply but not on the third ply, or wherein the first ply and the third ply have been embossed together to form the third embossments on the first ply and the third ply.

18 . The coreless roll of a tissue paper product of claim 16 , wherein the first ply, the third ply, and the fourth ply have been embossed together to form the first embossments on the first ply, the third ply, and the fourth ply, and

wherein, optionally, the first ply, the third ply, and the fourth ply have been embossed together to form the third embossments on the first ply, the third ply, and the fourth ply, or

wherein, optionally, the third embossments have been formed on the first ply and the third ply, but not on the fourth ply, or

wherein, optionally, the third embossments have been formed on the first ply, but not on the third ply and the fourth ply.

19 . The coreless roll of a tissue paper product of claim 16 , wherein the third ply and the fourth ply have been embossed together separately from the first ply and the second ply, or

wherein one of the third ply and the fourth ply has been separately embossed from the first ply and the second ply, and the other one of the third ply and the fourth ply is unembossed, or

wherein the third ply and the fourth ply are unembossed.

20 . The coreless roll of a tissue paper product of claim 16 , wherein the first ply and the third ply have been embossed together to form the first embossments on the first ply and the third ply,

wherein the fourth ply and the second ply have been embossed together to form the second embossments on the fourth ply and the second ply, and

wherein, optionally, the first ply and the third ply have been embossed together to form the third embossments on the first ply and the third ply, or wherein the third embossments have been formed only on the first ply but not on the third ply.

21 . The coreless roll of a tissue paper product of claim 16 ,

wherein the first embossments have been formed by the heated embossing roll, and/or,

wherein the second embossments have been formed by a second heated embossing roll, and/or,

wherein the third embossments have been formed by the heated embossing roll or a third heated embossing roll, and/or,

wherein, optionally, the first ply has been moistened, prior to having been embossed, with an amount of liquid, such as water, in the range of 2% to 12% of the basis weight of the first ply, or optionally 4% to 10% of the basis weight of the first ply, wherein the liquid optionally is provided with one or several additives, or wherein the first ply has not been moistened with a liquid prior to having been embossed.

22 . The coreless roll of a tissue paper product of claim 14 , wherein a geometrical mean tensile strength of tissue paper product of the coreless roll lies in a range of 170 N/m to 370 N/m, optionally 200 N/m to 370 N/m, or 220 N/m to 370 N/m.

23 . The coreless roll of a tissue paper product of claim 14 , wherein the third ply is made of Conventional Wet Press (CWP) paper and the fourth ply is made of Conventional Wet Press (CWP) paper; or

wherein the third ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT, and the fourth ply is made of Conventional Wet Press (CWP) paper; or

wherein the third ply is made of Conventional Wet Press (CWP) paper and the fourth ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT; or

wherein the third ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT, and the fourth ply is a structured paper ply, such as a ply made of TAD, UCTAD, eTAD, Atmos, or NTT.

24 . The coreless roll of a tissue paper product of claim 3 , wherein the first embossments cover between 1% and 20% of a total surface of the first ply, optionally between 2% and 10%, or between 3% and 6%, and/or

wherein a density of the third embossments is in a range of 25 to 120 embossments/cm 2 , optionally 40 to 100 embossments/cm 2 , or 50 to 80 embossments/cm 2 .

25 . The coreless roll of a tissue paper product of claim 1 , wherein the grammage of the first ply is in a range of 15 to 30 g/m 2 , optionally 16 to 25 g/m 2 , or 18 to 22 g/m 2 , and/or wherein the grammage of the second ply is in a range of 12 to 30 g/m 2 , optionally 14 to 25 g/m 2 , or 15 to 23 g/m 2 .

26 . The coreless roll of a tissue paper product of claim 1 ,

wherein the coreless roll has a radial compression strength of 20N or more, optionally of 25N or more, or of 30N or more.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 29, 2022
From: JEANNOT, SÉBASTIEN; WEISANG, NICOLAS
To: ESSITY HYGIENE AND HEALTH AKTIEBOLAG
Reel/Frame 062236/0203 →
Priority Claims (1)
WO PCT/IB2020/000595 · Jul 3, 2020 · international
Continuity (1)
Related Publication 20230250591A1 · Aug 10, 2023
References Cited (400)
US 2177490A · Kieffer · 1939 [cited by applicant]
US 3337388A · Wosaba · 1967 [cited by applicant]
US 3414459A · Wells · 1968 [cited by applicant]
US 3556907A · Nystrand · 1971 [cited by applicant]
US 3738905A · Thomas · 1973 [cited by applicant]
US 3867225A · Nystrand · 1975 [cited by applicant]
US 3953638A · Kemp · 1976 [cited by applicant]
US 3998690A · Lyness et al. · 1976 [cited by applicant]
US 4181068A · Pollock · 1980 [cited by applicant]
US 4284465A · Walbrun · 1981 [cited by applicant]
US 4320162A · Schulz · 1982 [cited by applicant]
US 4339088A · Niedermeyer · 1982 [cited by applicant]
US 4376671A · Schulz · 1983 [cited by applicant]
US 4487378A · Kobayashi · 1984 [cited by applicant]
US 4671983A · Burt · 1987 [cited by applicant]
US 5468323A · McNeil · 1995 [cited by applicant]
US 5685954A · Marinack et al. · 1997 [cited by applicant]
US 5779860A · Hollenberg · 1998 [cited by applicant]
US 5900114A · Brown et al. · 1999 [cited by applicant]
US 5922439A · Bredenick et al. · 1999 [cited by applicant]
US 6077390A · Salman et al. · 2000 [cited by applicant]
US 6080276A · Burgess · 2000 [cited by applicant]
US 6102313A · Salzsauler et al. · 2000 [cited by applicant]
US 6544386B1 · Krzysik et al. · 2003 [cited by applicant]
US 6551691B1 · Hoeft et al. · 2003 [cited by applicant]
US 6599614B1 · Roussel et al. · 2003 [cited by applicant]
US 6610173B1 · Lindsay et al. · 2003 [cited by applicant]
US 6746558B2 · Hoeft et al. · 2004 [cited by applicant]
US 6805766B1 · Roussel et al. · 2004 [cited by applicant]
US 6913673B2 · Baggot et al. · 2005 [cited by applicant]
US 7026037B2 · Lefebvre et al. · 2006 [cited by applicant]
US 7166189B2 · Burazin et al. · 2007 [cited by applicant]
US 7291379B2 · Biagiotti · 2007 [cited by applicant]
US 7785696B2 · Boatman et al. · 2010 [cited by applicant]
US 7827907B2 · Koivukunnas et al. · 2010 [cited by applicant]
US 7829177B2 · Russell et al. · 2010 [cited by applicant]
US 7842163B2 · Nickel et al. · 2010 [cited by applicant]
US 7967951B2 · Suzuki et al. · 2011 [cited by applicant]
US 7971526B2 · Blenke et al. · 2011 [cited by applicant]
US 7992818B2 · Maddaleni et al. · 2011 [cited by applicant]
US 8158047B2 · Schulz et al. · 2012 [cited by applicant]
US 8425730B2 · Biagiotti · 2013 [cited by applicant]
US 8535780B2 · Wojcik et al. · 2013 [cited by applicant]
US 8597469B2 · Biagiotti · 2013 [cited by applicant]
US 8708020B2 · Schutz · 2014 [cited by applicant]
US 8920905B2 · Sauter et al. · 2014 [cited by applicant]
US 8974892B2 · Nencioni et al. · 2015 [cited by applicant]
US 9034478B2 · Weisang et al. · 2015 [cited by applicant]
US 9090040B2 · Sauter et al. · 2015 [cited by applicant]
US 9284147B2 · Techlin · 2016 [cited by applicant]
US 9365376B2 · Wojcik et al. · 2016 [cited by applicant]
US 9375116B2 · Graff et al. · 2016 [cited by applicant]
US 9458574B2 · Myangiro et al. · 2016 [cited by applicant]
US 9637862B2 · Saas et al. · 2017 [cited by applicant]
US 9663900B2 · Jeannot et al. · 2017 [cited by applicant]
US 10213066B2 · Weisang et al. · 2019 [cited by applicant]
US 10280567B2 · Vogt et al. · 2019 [cited by applicant]
US 10350850B2 · Roesch et al. · 2019 [cited by applicant]
US 10463204B2 · Barredo · 2019 [cited by applicant]
US 10654239B2 · Stefani · 2020 [cited by applicant]
US 10696004B2 · Dettori et al. · 2020 [cited by applicant]
US 10814587B2 · Kleinwaechter et al. · 2020 [cited by applicant]
US 11090900B2 · Kraus et al. · 2021 [cited by applicant]
US 11280051B2 · Satake Neto et al. · 2022 [cited by applicant]
US 11346058B2 · Pleyber et al. · 2022 [cited by applicant]
US 11491699B2 · Yoshimura · 2022 [cited by applicant]
US 11987030B2 · Dwiggins · 2024 [cited by applicant]
US 12018439B2 · Satake Neto et al. · 2024 [cited by applicant]
US 12071730B2 · Pleyber et al. · 2024 [cited by applicant]
US 20020088596A1 · Lamb · 2002 [cited by applicant]
US 20020197346A1 · Papadopoulos · 2002 [cited by applicant]
US 20030026953A1 · Müller · 2003 [cited by applicant]
US 20030111169A1 · Baggot et al. · 2003 [cited by applicant]
US 20030118784A1 · Hollmark · 2003 [cited by applicant]
US 20030129363A1 · Hoeft et al. · 2003 [cited by applicant]
US 20040028935A1 · Hauke · 2004 [cited by applicant]
US 20040166290A1 · Sembritzki et al. · 2004 [cited by applicant]
US 20050069679A1 · Stelljes et al. · 2005 [cited by applicant]
US 20050098281A1 · Schulz et al. · 2005 [cited by applicant]
US 20050178513A1 · Russell · 2005 [cited by examiner]
US 20060065382A1 · Burazin et al. · 2006 [cited by applicant]
US 20060070714A1 · Perini · 2006 [cited by applicant]
US 20060130985A1 · Beuther et al. · 2006 [cited by applicant]
US 20060222819A1 · Gambini · 2006 [cited by applicant]
US 20060283538A1 · Schulz et al. · 2006 [cited by applicant]
US 20070003736A1 · Saarvali et al. · 2007 [cited by applicant]
US 20070062658A1 · Wiwi et al. · 2007 [cited by applicant]
US 20070092700A1 · Maddaleni et al. · 2007 [cited by applicant]
US 20070093157A1 · Shannon et al. · 2007 [cited by applicant]
US 20070137813A1 · Nickel et al. · 2007 [cited by applicant]
US 20070184246A1 · Nencioni et al. · 2007 [cited by applicant]
US 20070218248A1 · Mansson et al. · 2007 [cited by applicant]
US 20080183708A1 · Chen et al. · 2008 [cited by applicant]
US 20090162597A1 · Barredo et al. · 2009 [cited by applicant]
US 20090226670A1 · Schuetz · 2009 [cited by applicant]
US 20090255640A1 · Morin et al. · 2009 [cited by applicant]
US 20090297781A1 · Huss et al. · 2009 [cited by applicant]
US 20100021696A1 · Hill et al. · 2010 [cited by applicant]
US 20100028621A1 · Byrne et al. · 2010 [cited by applicant]
US 20100183350A1 · Sauter et al. · 2010 [cited by applicant]
US 20100183850A1 · Sauter et al. · 2010 [cited by applicant]
US 20100224338A1 · Harper et al. · 2010 [cited by applicant]
US 20100229738A1 · Hirota et al. · 2010 [cited by applicant]
US 20100239825A1 · Sheehan et al. · 2010 [cited by applicant]
US 20100295214A1 · Boatman et al. · 2010 [cited by applicant]
US 20110079671A1 · Wojcik et al. · 2011 [cited by applicant]
US 20110123773A1 · Lofink et al. · 2011 [cited by applicant]
US 20110311345A1 · McNeil · 2011 [cited by applicant]
US 20120152445A1 · Barredo et al. · 2012 [cited by applicant]
US 20120156447A1 · Hein et al. · 2012 [cited by applicant]
US 20120164426A1 · Barredo et al. · 2012 [cited by applicant]
US 20120244241A1 · McNeil · 2012 [cited by applicant]
US 20120255671A1 · Wallstabe et al. · 2012 [cited by applicant]
US 20130216789A1 · Kraus et al. · 2013 [cited by applicant]
US 20130327876A1 · Wojcik et al. · 2013 [cited by applicant]
US 20140224919A1 · Bixler et al. · 2014 [cited by applicant]
US 20150184342A1 · Saas et al. · 2015 [cited by applicant]
US 20150225903A1 · Jeannot et al. · 2015 [cited by applicant]
US 20150298420A1 · Gungner et al. · 2015 [cited by applicant]
US 20170274616A1 · Greenfield · 2017 [cited by applicant]
US 20170280946A1 · Weisang et al. · 2017 [cited by applicant]
US 20170328011A1 · Sealey et al. · 2017 [cited by applicant]
US 20180014699A1 · Barredo · 2018 [cited by applicant]
US 20180104928A1 · Dwiggins · 2018 [cited by applicant]
US 20180142422A1 · Baum et al. · 2018 [cited by applicant]
US 20180187377A1 · Ziegenbein · 2018 [cited by applicant]
US 20180216398A1 · Veerasamy · 2018 [cited by applicant]
US 20190061302A1 · Barnholtz et al. · 2019 [cited by applicant]
US 20190063004A1 · Barnholtz · 2019 [cited by applicant]
US 20190078263A1 · Glass et al. · 2019 [cited by applicant]
US 20190136457A1 · Lindsay et al. · 2019 [cited by applicant]
US 20190301099A1 · Montagnani et al. · 2019 [cited by applicant]
US 20200011014A1 · Pleyber · 2020 [cited by examiner]
US 20200156891A1 · Kurosaki · 2020 [cited by applicant]
US 20200263361A1 · Weisang · 2020 [cited by applicant]
US 20200277737A1 · Weisang · 2020 [cited by applicant]
US 20200298525A1 · Dwiggins · 2020 [cited by applicant]
US 20200324506A1 · Picchi et al. · 2020 [cited by applicant]
US 20200384718A1 · Picchi et al. · 2020 [cited by applicant]
US 20210070005A1 · Kumar et al. · 2021 [cited by applicant]
US 20210122561A1 · Lemke et al. · 2021 [cited by applicant]
US 20210180260A1 · Satake Neto et al. · 2021 [cited by applicant]
US 20210292972A1 · Lecount et al. · 2021 [cited by applicant]
US 20210310197A1 · Lecount et al. · 2021 [cited by applicant]
US 20210381172A1 · Goulet et al. · 2021 [cited by applicant]
US 20220010498A1 · Pleyber et al. · 2022 [cited by applicant]
US 20220112642A1 · Giurlani et al. · 2022 [cited by applicant]
US 20220154409A1 · Curley et al. · 2022 [cited by applicant]
US 20220168925A1 · Giurlani et al. · 2022 [cited by applicant]
US 20220275584A1 · Satake Neto et al. · 2022 [cited by applicant]
US 20230146893A1 · Pieroni et al. · 2023 [cited by applicant]
US 20230249431A1 · Barredo et al. · 2023 [cited by applicant]
US 20230265617A1 · Weisang et al. · 2023 [cited by applicant]
US 20230287630A1 · Weisang et al. · 2023 [cited by applicant]
US 20230295878A1 · Arnoul-Jarriault et al. · 2023 [cited by applicant]
US 20230295880A1 · Jeannot · 2023 [cited by applicant]
US 20240117566A1 · Skarius et al. · 2024 [cited by applicant]
US 20240209575A1 · Bailey et al. · 2024 [cited by applicant]
US 20240229362A1 · Kientz et al. · 2024 [cited by applicant]
US 20250250743A1 · Weisang et al. · 2025 [cited by applicant]
US 20250250744A1 · Weisang et al. · 2025 [cited by applicant]
CA 2049552A1 · 1992 [cited by applicant]
CA 2096140A1 · 1993 [cited by applicant]
CA 2776477C · 2018 [cited by applicant]
CL 200501067 · 2006 [cited by applicant]
CL 200803570 · 2009 [cited by applicant]
CL 2014000030A1 · 2014 [cited by applicant]
CL 202101610 · 2021 [cited by applicant]
CL 202203775 · 2022 [cited by applicant]
CL 202300009 · 2023 [cited by applicant]
CL 202300010 · 2023 [cited by applicant]
CN 1326523A · 2001 [cited by applicant]
CN 102143837A · 2011 [cited by applicant]
CN 102574354A · 2012 [cited by applicant]
CN 104136683A · 2014 [cited by applicant]
CN 104302471A · 2015 [cited by applicant]
CN 104520506A · 2015 [cited by applicant]
CN 107250013A · 2017 [cited by applicant]
CN 108431316A · 2018 [cited by applicant]
CN 207954831U · 2018 [cited by applicant]
CN 109310794A · 2019 [cited by applicant]
CN 110268116A · 2019 [cited by applicant]
CN 110914037A · 2020 [cited by applicant]
CN 210362711U · 2020 [cited by applicant]
CN 111148876A · 2020 [cited by applicant]
CN 111727288A · 2020 [cited by applicant]
CN 112218985A · 2021 [cited by applicant]
CN 115735031A · 2023 [cited by applicant]
CN 118541524A · 2024 [cited by applicant]
CO 5031318A1 · 2001 [cited by applicant]
CO 5031322A1 · 2001 [cited by applicant]
CO 5200825A1 · 2002 [cited by applicant]
CO 5650179A2 · 2006 [cited by applicant]
CO 2017008071A2 · 2017 [cited by applicant]
CO 2018010262A2 · 2018 [cited by applicant]
DE 10137116A1 · 2003 [cited by applicant]
DE 20313418U1 · 2003 [cited by applicant]
DE 102005055707A1 · 2007 [cited by applicant]
EP 0264676A1 · 1988 [cited by applicant]
EP 338792A2 · 1989 [cited by applicant]
EP 426288A2 · 1991 [cited by applicant]
EP 499942A2 · 1992 [cited by applicant]
EP 668152A1 · 1995 [cited by applicant]
EP 739708A2 · 1996 [cited by applicant]
EP 0701641B1 · 1997 [cited by applicant]
EP 0668152B1 · 1998 [cited by applicant]
EP 934738A1 · 1999 [cited by applicant]
EP 1081284A1 · 2001 [cited by applicant]
EP 1208965A2 · 2002 [cited by applicant]
EP 0813382B1 · 2002 [cited by applicant]
EP 1321570A2 · 2003 [cited by applicant]
EP 1321576A2 · 2003 [cited by applicant]
EP 1338412A1 · 2003 [cited by applicant]
EP 1400199A · 2004 [cited by applicant]
EP 1464263A1 · 2004 [cited by applicant]
EP 1907199A1 · 2008 [cited by applicant]
EP 1996395A1 · 2008 [cited by applicant]
EP 2044264A1 · 2009 [cited by applicant]
EP 2095935A1 · 2009 [cited by applicant]
EP 2261420A1 · 2010 [cited by applicant]
EP 2292840A1 · 2011 [cited by applicant]
EP 2353859B1 · 2011 [cited by applicant]
EP 2360015A1 · 2011 [cited by applicant]
EP 2664451A1 · 2013 [cited by applicant]
EP 2692948A1 · 2014 [cited by applicant]
EP 2754553A2 · 2014 [cited by applicant]
EP 2884001A1 · 2015 [cited by applicant]
EP 2998436A1 · 2016 [cited by applicant]
EP 3143203A1 · 2017 [cited by applicant]
EP 3436087A1 · 2019 [cited by applicant]
EP 2925202B1 · 2019 [cited by applicant]
EP 4166314A2 · 2023 [cited by applicant]
EP 4176125B1 · 2024 [cited by applicant]
EP 4077808B1 · 2025 [cited by applicant]
EP 4176124B1 · 2025 [cited by applicant]
ES 2295354T3 · 2008 [cited by applicant]
ES 2339668T3 · 2010 [cited by applicant]
ES 2578830A2 · 2016 [cited by applicant]
ES 2990036T3 · 2024 [cited by applicant]
GB 1259521A · 1972 [cited by applicant]
GB 2255745A · 1992 [cited by applicant]
IT MI951197A1 · 1996 [cited by applicant]
IT 201800006097A1 · 2019 [cited by applicant]
JP 2006045690A · 2007 [cited by applicant]
JP 2007136861A · 2007 [cited by applicant]
JP 2008094067A · 2008 [cited by applicant]
JP 2008138310A · 2008 [cited by applicant]
JP 4649118B2 · 2011 [cited by applicant]
JP 2012110407A · 2012 [cited by applicant]
JP 2015074098A · 2015 [cited by applicant]
JP 2019188021A · 2019 [cited by applicant]
JP 2020072992A · 2020 [cited by applicant]
MX 2014012792A · 2015 [cited by applicant]
WO 9406623A1 · 1994 [cited by applicant]
WO 9711228A1 · 1997 [cited by applicant]
WO 9720107A1 · 1997 [cited by applicant]
WO 9733043A1 · 1997 [cited by applicant]
WO 9743483A1 · 1997 [cited by applicant]
WO 9743484A1 · 1997 [cited by applicant]
WO 9821410A1 · 1998 [cited by applicant]
WO 9847706A1 · 1998 [cited by applicant]
WO 9915332A1 · 1999 [cited by applicant]
WO 9923290A1 · 1999 [cited by applicant]
WO 9923299A1 · 1999 [cited by applicant]
WO 9936253A1 · 1999 [cited by applicant]
WO 9945205A1 · 1999 [cited by applicant]
WO 9953140A1 · 1999 [cited by applicant]
WO 9959511A2 · 1999 [cited by applicant]
WO 0061358A1 · 2000 [cited by applicant]
WO 0125537A1 · 2001 [cited by applicant]
WO 0147699A1 · 2001 [cited by applicant]
WO 0148314A2 · 2001 [cited by applicant]
WO 0202869A2 · 2002 [cited by applicant]
WO 02072340A2 · 2002 [cited by applicant]
WO 02103112A1 · 2002 [cited by applicant]
WO 03043806A2 · 2003 [cited by applicant]
WO 03045681A1 · 2003 [cited by applicant]
WO 03059139A1 · 2003 [cited by applicant]
WO 03072344A1 · 2003 [cited by applicant]
WO 2004042142A1 · 2004 [cited by applicant]
WO 2004094726A1 · 2004 [cited by applicant]
WO 2005064044A1 · 2005 [cited by applicant]
WO 2005080677A2 · 2005 [cited by applicant]
WO 2005095100A1 · 2005 [cited by applicant]
WO 2006133389A2 · 2006 [cited by applicant]
WO 2007030592A2 · 2007 [cited by applicant]
WO 2007046124A1 · 2007 [cited by applicant]
WO 2007070129A1 · 2007 [cited by applicant]
WO 2007071734 · 2007 [cited by applicant]
WO 2007078363A1 · 2007 [cited by applicant]
WO 2007103433A2 · 2007 [cited by applicant]
WO 2008048151A1 · 2008 [cited by applicant]
WO 2008069147A1 · 2008 [cited by applicant]
WO 2010009769A1 · 2010 [cited by applicant]
WO 2010023616A2 · 2010 [cited by applicant]
WO 2010086837A2 · 2010 [cited by applicant]
WO 2010135074A1 · 2010 [cited by applicant]
WO 2010139759A1 · 2010 [cited by applicant]
WO 2011078755A1 · 2011 [cited by applicant]
WO 2013126531A1 · 2013 [cited by applicant]
WO 2013179109A2 · 2013 [cited by applicant]
WO 2014020424A1 · 2014 [cited by applicant]
WO 2015175281A1 · 2015 [cited by applicant]
WO 20150186052A1 · 2015 [cited by applicant]
WO 2016132168A1 · 2016 [cited by applicant]
WO 2016159966A1 · 2016 [cited by applicant]
WO 2017019421A1 · 2017 [cited by applicant]
WO 2017037273A1 · 2017 [cited by applicant]
WO 2017134846A1 · 2017 [cited by applicant]
WO 2017168195A1 · 2017 [cited by applicant]
WO 2017196516A1 · 2017 [cited by applicant]
WO 2017197405A1 · 2017 [cited by applicant]
WO 2017209738A1 · 2017 [cited by applicant]
WO 201873985A1 · 2018 [cited by applicant]
WO 2018166572A1 · 2018 [cited by applicant]
WO 2018217599A1 · 2018 [cited by applicant]
WO 2018217602A1 · 2018 [cited by applicant]
WO 2018229676A1 · 2018 [cited by applicant]
WO 201904225A1 · 2019 [cited by applicant]
WO 201959180A1 · 2019 [cited by applicant]
WO 2019064045A1 · 2019 [cited by applicant]
WO 2019064046A1 · 2019 [cited by applicant]
WO WO2019064044A1 · 2019 [cited by examiner]
WO WO2019203699A1 · 2019 [cited by examiner]
WO 2019219168A1 · 2019 [cited by applicant]
WO 2020068839A1 · 2020 [cited by applicant]
WO 2020128551A1 · 2020 [cited by applicant]
WO 2021126026A1 · 2021 [cited by applicant]
WO 2022003383A1 · 2022 [cited by applicant]
WO 2024226558A1 · 2024 [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000595; International Filing Date: Jul. 3, 2020; Date of Mailing: Apr. 7, 2021; 17 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2021/000458; International Filing Date: Jul. 2, 2021; Date of Mailing: Nov. 2, 2021; 19 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Non-Final Office Action mailed Jun. 23, 2023; 186 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Notice of Allowance dated Sep. 20, 2023; 8 pages. [cited by applicant]
CN Office Action with English Translation; CN Application No. 202180047021.7; Date Mailed: Feb. 24, 2024; pp. 1-7. [cited by applicant]
Chilean Application No. 202203662; CL Office Action with English translation dated Mar. 21, 2024; 20 pages. [cited by applicant]
Chinese Application No. 202080102548.0; First Office Action dated Apr. 3, 2024; 25 pages. [cited by applicant]
International Preliminary Report on Patentability for International Application No. PCT/IB2020/000586; International Filing Date: Jul. 3, 2020; Date of Mailing: Sep. 29, 2022; 25 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000583; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 24, 2021; 13 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000586; International Filing Date: Jul. 3, 2020; Date of Mailing: Mar. 9, 2021; 12 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000588; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 22, 2021; 11 pages. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000592; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 26, 2021; 15 pages. [cited by applicant]
Written Opinion of the International Preliminary Examining Authority for International Application No. PCT/IB2020/000586; International Filing Date: Jul. 3, 2020; Date of Mailing: May 19, 2022; 8 pages. [cited by applicant]
Mexican Application No. MX/E/2023/050579; Third Party Observation dated Jul. 17, 2023; 100 pages. [cited by applicant]
Mexican Application No. MX/E/2023/050580; Third Party Observation dated Jul. 17, 2023; 50 pages. [cited by applicant]
Chinese Application No. 202080102451.X; First Office Action dated Dec. 23, 2023; 29 pages. [cited by applicant]
Chinese Application No. 202080102393.0; Office Action with English translation dated Sep. 20, 2023; 11 pages. [cited by applicant]
Chinese Application No. 202080102449.2; Chinese Office Action with English translation dated Sep. 7, 2023; 20 pages. [cited by applicant]
Chinese Application No. 202180047021.7; Chinese Office Action with English translation dated Sep. 22, 2023; 28 pages. [cited by applicant]
Chinese Application No. 202080102390.7; Chinese Office Action with English translation dated Aug. 1, 2023; 18 pages. [cited by applicant]
Chilean Application No. 202203663; CL Office Action with English translation dated Jan. 8, 2024; 19 pages. [cited by applicant]
Chinese Application No. 202080102449.2; Chinese Office Action with English translation dated Feb. 3, 2024; 38 pages. [cited by applicant]
U.S. Appl. No. 18/545,976, filed Dec. 19, 2023; Non-Final Office Action mailed Jul. 2, 2024; 56 pages. [cited by applicant]
Chinese Application No. 202080102451.X; Office Action with English dated Jul. 11, 2024; 31 pages. [cited by applicant]
Chinese Application No. 202080102647.9; Office Action with English dated Jul. 23, 2024; 26 pages. [cited by applicant]
Colombian Application No. NC2022/0017942; Office Action with English dated May 20, 2024; 32 pages. [cited by applicant]
Colombian Application No. NC2023/0001171; Office Action with English dated Jul. 24, 2024; 52 pages. [cited by applicant]
European Application No. 20753412.4; Communication pursuant to Article 94(3) EPC dated Jun. 12, 2024; 6 pgs. [cited by applicant]
International Search Report & Written Opinion for International Application No. PCT/IB2020/000589; International Filing Date: Jul. 3, 2020; Date of Mailing: Feb. 24, 2021; 11 pages. [cited by applicant]
U.S. Appl. No. 18/012,956, filed Dec. 26, 2022; Notice of Allowance mailed Mar. 18, 2024; 97pages. [cited by applicant]
Chilean Application No. 202203662; CL Office Action with English translation dated Aug. 16, 2024; 18 pages. [cited by applicant]
Chinese Application No. 202080102548.0; Office Action with English translation dated Sep. 12, 2024; 28 pages. [cited by applicant]
U.S. Appl. No. 18/012,956; Non-Final Office Action dated Sep. 28, 2024; 22 pages. [cited by applicant]
Chilean Application No. 202203775; Office Action with English dated Sep. 5, 2024; 35 pages. [cited by applicant]
U.S. Appl. No. 18/012,966; Non-Final Office Action dated Aug. 29, 2024; 68 pages. [cited by applicant]
U.S. Appl. No. 18/013,667; Restriction Requirement dated Sep. 17, 2024; 8 pages. [cited by applicant]
U.S. Appl. No. 18/013,667; Non-Final Office Action dated Dec. 17, 2024; 112 pages. [cited by applicant]
U.S. Appl. No. 18/013,703; Restriction Requirement dated Dec. 18, 2024; 53 pages. [cited by applicant]
U.S. Appl. No. 18/545,976; Final Office Action dated Dec. 4, 2024; 37 pages. [cited by applicant]
Colombian Office Action NC2023/0001170; Office Action with English translation dated Aug. 20, 2024; 19 pages. [cited by applicant]
Colombian Patent Office, Office Action issued in CO NC2019/0010000 dated Aug. 9, 2021 with partial English Translation (15 apges). [cited by applicant]
International Searching Authority, Search Report and Written Opinion issued in International Application No. PCT/EP2017/055795 mailed Nov. 9, 2017 (14 pages). [cited by applicant]
National Intellectual Property Administration (CNIPA) of the People's Republic of China, Office Action issued in App. No. 201780086232.5 dated Nov. 19, 2021 with English Translation (17 pages). [cited by applicant]
U.S. Appl. No. 16/491,006; Notice of Allowance dated Feb. 4, 2022; 34 pages. [cited by applicant]
U.S. Appl. No. 18/012,955; Non-Final Office Action dated Nov. 5, 2024; 204 pages. [cited by applicant]
U.S. Appl. No. 18/013,817; Non-Final Office Action dated Jan. 13, 2025; 107 pages. [cited by applicant]
Chilean Application No. 202300008; Office Action with English translation dated Nov. 20, 2024; 25 pages. [cited by applicant]
Chilean Application No. 202300009; Office Action with English translation dated Nov. 12, 2024; 34 pages. [cited by applicant]
Chilean Application No. 202300010; Office Action with English translation dated Nov. 14, 2024; 31 pages. [cited by applicant]
Chinese Application No. 202080102451X; Office Action with English translation dated Jan. 15, 2025; 31 pages. [cited by applicant]
Chinese Application No. 2020801025480; Office Action with English translation dated Jan. 3, 2025; 21 pages. [cited by applicant]
Colombian Application No. NC2022/0017942; Office Action with English translation dated Oct. 30, 2024; 29 pages. [cited by applicant]
Colombian Application No. NC2022/0018141; Office Action with English translation dated Oct. 30, 2024; 15 pages. [cited by applicant]
Colombian Application No. NC2023/0001168; Office Action with English translation dated Sep. 12, 2024; 24 pages. [cited by applicant]
Colombian Patent Application No. NC2023/0001172; Office Action with English translation dated Aug. 27, 2024; 16 pages. [cited by applicant]
Ukraine Application No. 22546/3A/24; Office Action with English translation dated Nov. 13, 2024; 13 pages. [cited by applicant]
U.S. Appl. No. 18/012,956; Final Office Action dated Feb. 14, 2025; 30 pages. [cited by applicant]
Chinese Application No. 202080102451X; Decision of Rejection dated Jan. 15, 2025; 31 pages. [cited by applicant]
Colombian Application No. NC2022/0018141; Office Action with English translation dated Feb. 25, 2025; 20 pages. [cited by applicant]
U.S. Appl. No. 18/545,976; Final Office Action dated Mar. 18, 2025; 15 pages. [cited by applicant]
U.S. Appl. No. 18/012,966; Final Office Action dated Apr. 16, 2025; 22 pages. [cited by applicant]
U.S. Appl. No. 18/724,456; Final Office Action dated Sep. 25, 2025; 70 pages. [cited by applicant]
U.S. Appl. No. 18/012,966; Non-Final Office Action dated Sep. 10, 2025; 38 pages. [cited by applicant]
Chemical Technology of Pulp and Papermaking, 3rd edition, vol. 2, edited by J.P. Kathy (US), Light Industry Press, Mar. 1988, pp. 365-366; With English Translation; 33 pages. [cited by applicant]
Chinese Application No. 202080102451.X; Office Action with English translation dated Jul. 21, 2025; 39 pages. [cited by applicant]
Papermaking II, Drying, by (Finland) Komanku et al., China Light Industry Press, Jul. 2018, pp. 128-130; 13 pages. [cited by applicant]
Ukraine Application No. a 2022 04975; Office Action with English translation dated Jun. 23, 2025; 13 pages. [cited by applicant]
U.S. Appl. No. 18/013,817; Non-Final Office Action dated Aug. 11, 2025; 16 pages. [cited by applicant]
Singapore Application No. 11202261481U; Office Action dated Apr. 29, 2025; 5 pages. [cited by applicant]
U.S. Appl. No. 18/013,817; Final Office Action dated May 5, 2025; 18 pages. [cited by applicant]